nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—CYP2D6—Lomustine—hematologic cancer	0.0444	0.0738	CbGbCtD
Ranolazine—CYP2D6—Idarubicin—hematologic cancer	0.0395	0.0658	CbGbCtD
Ranolazine—CYP2D6—Hydroxyurea—hematologic cancer	0.0336	0.0559	CbGbCtD
Ranolazine—CYP3A4—Bexarotene—hematologic cancer	0.0303	0.0505	CbGbCtD
Ranolazine—CYP2D6—Bortezomib—hematologic cancer	0.0292	0.0487	CbGbCtD
Ranolazine—CYP3A4—Lomustine—hematologic cancer	0.0282	0.0469	CbGbCtD
Ranolazine—CYP3A4—Busulfan—hematologic cancer	0.0282	0.0469	CbGbCtD
Ranolazine—CYP3A4—Thiotepa—hematologic cancer	0.0251	0.0418	CbGbCtD
Ranolazine—CYP2D6—Imatinib—hematologic cancer	0.0214	0.0357	CbGbCtD
Ranolazine—CYP3A4—Methoxsalen—hematologic cancer	0.0196	0.0325	CbGbCtD
Ranolazine—CYP2D6—Nilotinib—hematologic cancer	0.0195	0.0324	CbGbCtD
Ranolazine—CYP2D6—Vinorelbine—hematologic cancer	0.0193	0.0321	CbGbCtD
Ranolazine—CYP3A4—Bortezomib—hematologic cancer	0.0186	0.0309	CbGbCtD
Ranolazine—CYP3A4—Daunorubicin—hematologic cancer	0.0178	0.0296	CbGbCtD
Ranolazine—CYP3A4—Cytarabine—hematologic cancer	0.0157	0.0261	CbGbCtD
Ranolazine—CYP3A4—Teniposide—hematologic cancer	0.0155	0.0257	CbGbCtD
Ranolazine—CYP3A4—Ifosfamide—hematologic cancer	0.0143	0.0237	CbGbCtD
Ranolazine—CYP3A4—Imatinib—hematologic cancer	0.0136	0.0227	CbGbCtD
Ranolazine—CYP3A4—Ruxolitinib—hematologic cancer	0.0128	0.0213	CbGbCtD
Ranolazine—CYP3A4—Nilotinib—hematologic cancer	0.0124	0.0206	CbGbCtD
Ranolazine—CYP3A4—Vinorelbine—hematologic cancer	0.0123	0.0204	CbGbCtD
Ranolazine—CYP2D6—Vinblastine—hematologic cancer	0.0119	0.0198	CbGbCtD
Ranolazine—CYP3A4—Triamcinolone—hematologic cancer	0.0112	0.0187	CbGbCtD
Ranolazine—CYP3A4—Dasatinib—hematologic cancer	0.0109	0.0182	CbGbCtD
Ranolazine—CYP3A4—Mitoxantrone—hematologic cancer	0.0108	0.018	CbGbCtD
Ranolazine—CYP3A4—Betamethasone—hematologic cancer	0.00963	0.016	CbGbCtD
Ranolazine—CYP3A4—Prednisolone—hematologic cancer	0.00951	0.0158	CbGbCtD
Ranolazine—CYP3A4—Prednisone—hematologic cancer	0.00898	0.0149	CbGbCtD
Ranolazine—CYP2D6—Dexamethasone—hematologic cancer	0.00881	0.0147	CbGbCtD
Ranolazine—CYP3A4—Irinotecan—hematologic cancer	0.00851	0.0142	CbGbCtD
Ranolazine—CYP3A4—Vinblastine—hematologic cancer	0.00757	0.0126	CbGbCtD
Ranolazine—CYP3A4—Vincristine—hematologic cancer	0.00744	0.0124	CbGbCtD
Ranolazine—CYP2D6—Doxorubicin—hematologic cancer	0.00731	0.0122	CbGbCtD
Ranolazine—CYP3A4—Etoposide—hematologic cancer	0.00682	0.0113	CbGbCtD
Ranolazine—CYP3A4—Dexamethasone—hematologic cancer	0.0056	0.00932	CbGbCtD
Ranolazine—CYP3A4—Doxorubicin—hematologic cancer	0.00465	0.00774	CbGbCtD
Ranolazine—SCN5A—Axon guidance—PTPRC—hematologic cancer	9.36e-05	0.00208	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—hematologic cancer	8.91e-05	0.00198	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CCND3—hematologic cancer	8.74e-05	0.00194	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—hematologic cancer	8.49e-05	0.00189	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CREB1—hematologic cancer	8.46e-05	0.00188	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—GRB2—hematologic cancer	8.45e-05	0.00188	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—RAC2—hematologic cancer	8.45e-05	0.00188	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MET—hematologic cancer	8.44e-05	0.00188	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—hematologic cancer	8.43e-05	0.00187	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6R—hematologic cancer	8.25e-05	0.00183	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	8.24e-05	0.00183	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HSP90AA1—hematologic cancer	8.18e-05	0.00182	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ABL1—hematologic cancer	8.13e-05	0.0018	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NCOA3—hematologic cancer	8.08e-05	0.00179	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—SRC—hematologic cancer	8.05e-05	0.00179	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NCAM1—hematologic cancer	7.86e-05	0.00174	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—PTPN11—hematologic cancer	7.81e-05	0.00173	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HES1—hematologic cancer	7.68e-05	0.00171	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NCOR1—hematologic cancer	7.64e-05	0.0017	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—CREB1—hematologic cancer	7.57e-05	0.00168	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—FOXO1—hematologic cancer	7.45e-05	0.00165	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CTNNA1—hematologic cancer	7.43e-05	0.00165	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—MAPK3—hematologic cancer	7.41e-05	0.00165	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6R—hematologic cancer	7.38e-05	0.00164	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—GRB2—hematologic cancer	7.38e-05	0.00164	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—JAK1—hematologic cancer	7.29e-05	0.00162	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—ABL1—hematologic cancer	7.09e-05	0.00158	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—SLC35B2—hematologic cancer	7.08e-05	0.00157	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—MAP2K1—hematologic cancer	7.03e-05	0.00156	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—EPHX1—hematologic cancer	6.98e-05	0.00155	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTO1—hematologic cancer	6.98e-05	0.00155	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTO1—hematologic cancer	6.88e-05	0.00153	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PTPRC—hematologic cancer	6.68e-05	0.00148	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—UGT1A1—hematologic cancer	6.56e-05	0.00146	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—UGT1A1—hematologic cancer	6.47e-05	0.00144	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—JAK2—hematologic cancer	6.41e-05	0.00142	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—JAK1—hematologic cancer	6.37e-05	0.00141	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL1B—hematologic cancer	6.28e-05	0.00139	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—CASP3—hematologic cancer	6.26e-05	0.00139	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MAPK14—hematologic cancer	6.12e-05	0.00136	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—JUN—hematologic cancer	6.08e-05	0.00135	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDK4—hematologic cancer	6.03e-05	0.00134	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—MET—hematologic cancer	6.03e-05	0.00134	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HSP90AA1—hematologic cancer	5.84e-05	0.0013	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NOTCH1—hematologic cancer	5.8e-05	0.00129	CbGpPWpGaD
Ranolazine—Nausea—Carmustine—hematologic cancer	5.76e-05	0.000163	CcSEcCtD
Ranolazine—Epistaxis—Doxorubicin—hematologic cancer	5.75e-05	0.000163	CcSEcCtD
Ranolazine—Angiopathy—Methotrexate—hematologic cancer	5.74e-05	0.000162	CcSEcCtD
Ranolazine—Vomiting—Irinotecan—hematologic cancer	5.73e-05	0.000162	CcSEcCtD
Ranolazine—Vomiting—Mitoxantrone—hematologic cancer	5.73e-05	0.000162	CcSEcCtD
Ranolazine—Nausea—Alitretinoin—hematologic cancer	5.71e-05	0.000161	CcSEcCtD
Ranolazine—Visual impairment—Epirubicin—hematologic cancer	5.7e-05	0.000161	CcSEcCtD
Ranolazine—Mediastinal disorder—Methotrexate—hematologic cancer	5.7e-05	0.000161	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—MTR—hematologic cancer	5.69e-05	0.00126	CbGpPWpGaD
Ranolazine—Rash—Mitoxantrone—hematologic cancer	5.68e-05	0.000161	CcSEcCtD
Ranolazine—Rash—Irinotecan—hematologic cancer	5.68e-05	0.000161	CcSEcCtD
Ranolazine—Dermatitis—Irinotecan—hematologic cancer	5.68e-05	0.00016	CcSEcCtD
Ranolazine—Dermatitis—Mitoxantrone—hematologic cancer	5.68e-05	0.00016	CcSEcCtD
Ranolazine—Headache—Irinotecan—hematologic cancer	5.65e-05	0.00016	CcSEcCtD
Ranolazine—Headache—Mitoxantrone—hematologic cancer	5.65e-05	0.00016	CcSEcCtD
Ranolazine—Nausea—Ifosfamide—hematologic cancer	5.64e-05	0.000159	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—EP300—hematologic cancer	5.61e-05	0.00125	CbGpPWpGaD
Ranolazine—Feeling abnormal—Triamcinolone—hematologic cancer	5.61e-05	0.000158	CcSEcCtD
Ranolazine—Anxiety—Prednisone—hematologic cancer	5.59e-05	0.000158	CcSEcCtD
Ranolazine—Vomiting—Gemcitabine—hematologic cancer	5.58e-05	0.000158	CcSEcCtD
Ranolazine—Insomnia—Dexamethasone—hematologic cancer	5.58e-05	0.000158	CcSEcCtD
Ranolazine—Insomnia—Betamethasone—hematologic cancer	5.58e-05	0.000158	CcSEcCtD
Ranolazine—Bradycardia—Doxorubicin—hematologic cancer	5.57e-05	0.000157	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—PTPN11—hematologic cancer	5.57e-05	0.00124	CbGpPWpGaD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	5.57e-05	0.000157	CcSEcCtD
Ranolazine—Paraesthesia—Dexamethasone—hematologic cancer	5.54e-05	0.000157	CcSEcCtD
Ranolazine—Paraesthesia—Betamethasone—hematologic cancer	5.54e-05	0.000157	CcSEcCtD
Ranolazine—Mental disorder—Methotrexate—hematologic cancer	5.54e-05	0.000157	CcSEcCtD
Ranolazine—Rash—Gemcitabine—hematologic cancer	5.54e-05	0.000156	CcSEcCtD
Ranolazine—Dermatitis—Gemcitabine—hematologic cancer	5.53e-05	0.000156	CcSEcCtD
Ranolazine—Eye disorder—Epirubicin—hematologic cancer	5.53e-05	0.000156	CcSEcCtD
Ranolazine—Tinnitus—Epirubicin—hematologic cancer	5.52e-05	0.000156	CcSEcCtD
Ranolazine—Malnutrition—Methotrexate—hematologic cancer	5.5e-05	0.000156	CcSEcCtD
Ranolazine—Headache—Gemcitabine—hematologic cancer	5.5e-05	0.000155	CcSEcCtD
Ranolazine—Nausea—Vincristine—hematologic cancer	5.5e-05	0.000155	CcSEcCtD
Ranolazine—Cardiac disorder—Epirubicin—hematologic cancer	5.49e-05	0.000155	CcSEcCtD
Ranolazine—Hypoaesthesia—Doxorubicin—hematologic cancer	5.45e-05	0.000154	CcSEcCtD
Ranolazine—Dyspepsia—Dexamethasone—hematologic cancer	5.43e-05	0.000154	CcSEcCtD
Ranolazine—Dyspepsia—Betamethasone—hematologic cancer	5.43e-05	0.000154	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—GSTT1—hematologic cancer	5.41e-05	0.0012	CbGpPWpGaD
Ranolazine—Urinary tract disorder—Doxorubicin—hematologic cancer	5.41e-05	0.000153	CcSEcCtD
Ranolazine—Urticaria—Triamcinolone—hematologic cancer	5.4e-05	0.000153	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—CREB1—hematologic cancer	5.4e-05	0.0012	CbGpPWpGaD
Ranolazine—Oedema peripheral—Doxorubicin—hematologic cancer	5.39e-05	0.000152	CcSEcCtD
Ranolazine—Asthenia—Etoposide—hematologic cancer	5.38e-05	0.000152	CcSEcCtD
Ranolazine—Connective tissue disorder—Doxorubicin—hematologic cancer	5.38e-05	0.000152	CcSEcCtD
Ranolazine—Angiopathy—Epirubicin—hematologic cancer	5.37e-05	0.000152	CcSEcCtD
Ranolazine—Urethral disorder—Doxorubicin—hematologic cancer	5.37e-05	0.000152	CcSEcCtD
Ranolazine—Decreased appetite—Dexamethasone—hematologic cancer	5.37e-05	0.000152	CcSEcCtD
Ranolazine—Decreased appetite—Betamethasone—hematologic cancer	5.37e-05	0.000152	CcSEcCtD
Ranolazine—Nausea—Irinotecan—hematologic cancer	5.36e-05	0.000151	CcSEcCtD
Ranolazine—Nausea—Mitoxantrone—hematologic cancer	5.36e-05	0.000151	CcSEcCtD
Ranolazine—Mediastinal disorder—Epirubicin—hematologic cancer	5.33e-05	0.000151	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.33e-05	0.000151	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.33e-05	0.000151	CcSEcCtD
Ranolazine—Fatigue—Dexamethasone—hematologic cancer	5.32e-05	0.00015	CcSEcCtD
Ranolazine—Fatigue—Betamethasone—hematologic cancer	5.32e-05	0.00015	CcSEcCtD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	5.31e-05	0.00118	CbGpPWpGaD
Ranolazine—Pruritus—Etoposide—hematologic cancer	5.31e-05	0.00015	CcSEcCtD
Ranolazine—Shock—Prednisone—hematologic cancer	5.29e-05	0.000149	CcSEcCtD
Ranolazine—Arrhythmia—Epirubicin—hematologic cancer	5.29e-05	0.000149	CcSEcCtD
Ranolazine—Visual impairment—Doxorubicin—hematologic cancer	5.28e-05	0.000149	CcSEcCtD
Ranolazine—Nervous system disorder—Prednisone—hematologic cancer	5.27e-05	0.000149	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—IL6R—hematologic cancer	5.27e-05	0.00117	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—GRB2—hematologic cancer	5.27e-05	0.00117	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—MET—hematologic cancer	5.26e-05	0.00117	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CREBBP—hematologic cancer	5.26e-05	0.00117	CbGpPWpGaD
Ranolazine—Skin disorder—Prednisone—hematologic cancer	5.22e-05	0.000148	CcSEcCtD
Ranolazine—Nausea—Gemcitabine—hematologic cancer	5.22e-05	0.000147	CcSEcCtD
Ranolazine—Vomiting—Cisplatin—hematologic cancer	5.2e-05	0.000147	CcSEcCtD
Ranolazine—Hyperhidrosis—Prednisone—hematologic cancer	5.2e-05	0.000147	CcSEcCtD
Ranolazine—Vision blurred—Methotrexate—hematologic cancer	5.19e-05	0.000147	CcSEcCtD
Ranolazine—Mental disorder—Epirubicin—hematologic cancer	5.18e-05	0.000146	CcSEcCtD
Ranolazine—Rash—Cisplatin—hematologic cancer	5.16e-05	0.000146	CcSEcCtD
Ranolazine—Dermatitis—Cisplatin—hematologic cancer	5.16e-05	0.000146	CcSEcCtD
Ranolazine—Malnutrition—Epirubicin—hematologic cancer	5.15e-05	0.000146	CcSEcCtD
Ranolazine—Anorexia—Prednisone—hematologic cancer	5.12e-05	0.000145	CcSEcCtD
Ranolazine—Eye disorder—Doxorubicin—hematologic cancer	5.12e-05	0.000145	CcSEcCtD
Ranolazine—Tinnitus—Doxorubicin—hematologic cancer	5.1e-05	0.000144	CcSEcCtD
Ranolazine—Feeling abnormal—Betamethasone—hematologic cancer	5.09e-05	0.000144	CcSEcCtD
Ranolazine—Feeling abnormal—Dexamethasone—hematologic cancer	5.09e-05	0.000144	CcSEcCtD
Ranolazine—Cardiac disorder—Doxorubicin—hematologic cancer	5.08e-05	0.000144	CcSEcCtD
Ranolazine—Flatulence—Epirubicin—hematologic cancer	5.08e-05	0.000143	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—ABL1—hematologic cancer	5.06e-05	0.00112	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Betamethasone—hematologic cancer	5.05e-05	0.000143	CcSEcCtD
Ranolazine—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.05e-05	0.000143	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MAP2K1—hematologic cancer	5.02e-05	0.00112	CbGpPWpGaD
Ranolazine—Angiopathy—Doxorubicin—hematologic cancer	4.97e-05	0.00014	CcSEcCtD
Ranolazine—Dizziness—Etoposide—hematologic cancer	4.96e-05	0.00014	CcSEcCtD
Ranolazine—Muscle spasms—Epirubicin—hematologic cancer	4.95e-05	0.00014	CcSEcCtD
Ranolazine—Vertigo—Methotrexate—hematologic cancer	4.95e-05	0.00014	CcSEcCtD
Ranolazine—Mediastinal disorder—Doxorubicin—hematologic cancer	4.93e-05	0.000139	CcSEcCtD
Ranolazine—Leukopenia—Methotrexate—hematologic cancer	4.93e-05	0.000139	CcSEcCtD
Ranolazine—Urticaria—Dexamethasone—hematologic cancer	4.9e-05	0.000139	CcSEcCtD
Ranolazine—Urticaria—Betamethasone—hematologic cancer	4.9e-05	0.000139	CcSEcCtD
Ranolazine—Dizziness—Prednisolone—hematologic cancer	4.89e-05	0.000138	CcSEcCtD
Ranolazine—Arrhythmia—Doxorubicin—hematologic cancer	4.89e-05	0.000138	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—SRC—hematologic cancer	4.88e-05	0.00108	CbGpPWpGaD
Ranolazine—Asthenia—Triamcinolone—hematologic cancer	4.88e-05	0.000138	CcSEcCtD
Ranolazine—Abdominal pain—Dexamethasone—hematologic cancer	4.88e-05	0.000138	CcSEcCtD
Ranolazine—Abdominal pain—Betamethasone—hematologic cancer	4.88e-05	0.000138	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—PTPN11—hematologic cancer	4.87e-05	0.00108	CbGpPWpGaD
Ranolazine—Nausea—Cisplatin—hematologic cancer	4.86e-05	0.000137	CcSEcCtD
Ranolazine—Insomnia—Prednisone—hematologic cancer	4.86e-05	0.000137	CcSEcCtD
Ranolazine—Vision blurred—Epirubicin—hematologic cancer	4.85e-05	0.000137	CcSEcCtD
Ranolazine—Paraesthesia—Prednisone—hematologic cancer	4.83e-05	0.000136	CcSEcCtD
Ranolazine—Pruritus—Triamcinolone—hematologic cancer	4.81e-05	0.000136	CcSEcCtD
Ranolazine—Cough—Methotrexate—hematologic cancer	4.8e-05	0.000136	CcSEcCtD
Ranolazine—Mental disorder—Doxorubicin—hematologic cancer	4.8e-05	0.000136	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—HES1—hematologic cancer	4.79e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—FGF2—hematologic cancer	4.77e-05	0.00106	CbGpPWpGaD
Ranolazine—Vomiting—Etoposide—hematologic cancer	4.77e-05	0.000135	CcSEcCtD
Ranolazine—Malnutrition—Doxorubicin—hematologic cancer	4.77e-05	0.000135	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—NCOR1—hematologic cancer	4.76e-05	0.00106	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—hematologic cancer	4.75e-05	0.00106	CbGpPWpGaD
Ranolazine—Dyspepsia—Prednisone—hematologic cancer	4.73e-05	0.000134	CcSEcCtD
Ranolazine—Rash—Etoposide—hematologic cancer	4.73e-05	0.000134	CcSEcCtD
Ranolazine—Dermatitis—Etoposide—hematologic cancer	4.72e-05	0.000133	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—CREB1—hematologic cancer	4.71e-05	0.00105	CbGpPWpGaD
Ranolazine—Headache—Etoposide—hematologic cancer	4.7e-05	0.000133	CcSEcCtD
Ranolazine—Flatulence—Doxorubicin—hematologic cancer	4.7e-05	0.000133	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—NRAS—hematologic cancer	4.7e-05	0.00104	CbGpPWpGaD
Ranolazine—Decreased appetite—Prednisone—hematologic cancer	4.67e-05	0.000132	CcSEcCtD
Ranolazine—Rash—Prednisolone—hematologic cancer	4.66e-05	0.000132	CcSEcCtD
Ranolazine—Dermatitis—Prednisolone—hematologic cancer	4.66e-05	0.000132	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	4.65e-05	0.000131	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—FOXO1—hematologic cancer	4.64e-05	0.00103	CbGpPWpGaD
Ranolazine—Fatigue—Prednisone—hematologic cancer	4.63e-05	0.000131	CcSEcCtD
Ranolazine—Headache—Prednisolone—hematologic cancer	4.63e-05	0.000131	CcSEcCtD
Ranolazine—Vertigo—Epirubicin—hematologic cancer	4.63e-05	0.000131	CcSEcCtD
Ranolazine—Syncope—Epirubicin—hematologic cancer	4.62e-05	0.000131	CcSEcCtD
Ranolazine—Leukopenia—Epirubicin—hematologic cancer	4.61e-05	0.00013	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—IL6R—hematologic cancer	4.6e-05	0.00102	CbGpPWpGaD
Ranolazine—Constipation—Prednisone—hematologic cancer	4.6e-05	0.00013	CcSEcCtD
Ranolazine—Muscle spasms—Doxorubicin—hematologic cancer	4.58e-05	0.000129	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—JAK2—hematologic cancer	4.58e-05	0.00102	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTO1—hematologic cancer	4.56e-05	0.00101	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.55e-05	0.00101	CbGpPWpGaD
Ranolazine—Palpitations—Epirubicin—hematologic cancer	4.55e-05	0.000129	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—JAK1—hematologic cancer	4.54e-05	0.00101	CbGpPWpGaD
Ranolazine—Confusional state—Methotrexate—hematologic cancer	4.53e-05	0.000128	CcSEcCtD
Ranolazine—Loss of consciousness—Epirubicin—hematologic cancer	4.53e-05	0.000128	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTO1—hematologic cancer	4.5e-05	0.001	CbGpPWpGaD
Ranolazine—Dizziness—Triamcinolone—hematologic cancer	4.5e-05	0.000127	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—MAPK3—hematologic cancer	4.5e-05	0.000999	CbGpPWpGaD
Ranolazine—Cough—Epirubicin—hematologic cancer	4.49e-05	0.000127	CcSEcCtD
Ranolazine—Vision blurred—Doxorubicin—hematologic cancer	4.49e-05	0.000127	CcSEcCtD
Ranolazine—Nausea—Etoposide—hematologic cancer	4.45e-05	0.000126	CcSEcCtD
Ranolazine—Feeling abnormal—Prednisone—hematologic cancer	4.43e-05	0.000125	CcSEcCtD
Ranolazine—Asthenia—Betamethasone—hematologic cancer	4.43e-05	0.000125	CcSEcCtD
Ranolazine—Asthenia—Dexamethasone—hematologic cancer	4.43e-05	0.000125	CcSEcCtD
Ranolazine—Nervous system disorder—Methotrexate—hematologic cancer	4.41e-05	0.000124	CcSEcCtD
Ranolazine—Thrombocytopenia—Methotrexate—hematologic cancer	4.4e-05	0.000124	CcSEcCtD
Ranolazine—Gastrointestinal pain—Prednisone—hematologic cancer	4.4e-05	0.000124	CcSEcCtD
Ranolazine—Nausea—Prednisolone—hematologic cancer	4.39e-05	0.000124	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—MAP2K1—hematologic cancer	4.38e-05	0.000973	CbGpPWpGaD
Ranolazine—Anxiety—Epirubicin—hematologic cancer	4.37e-05	0.000123	CcSEcCtD
Ranolazine—Pruritus—Dexamethasone—hematologic cancer	4.37e-05	0.000123	CcSEcCtD
Ranolazine—Pruritus—Betamethasone—hematologic cancer	4.37e-05	0.000123	CcSEcCtD
Ranolazine—Skin disorder—Methotrexate—hematologic cancer	4.36e-05	0.000123	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	4.36e-05	0.000123	CcSEcCtD
Ranolazine—Hyperhidrosis—Methotrexate—hematologic cancer	4.34e-05	0.000123	CcSEcCtD
Ranolazine—Vomiting—Triamcinolone—hematologic cancer	4.33e-05	0.000122	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—UGT1A1—hematologic cancer	4.29e-05	0.000953	CbGpPWpGaD
Ranolazine—Rash—Triamcinolone—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Ranolazine—Dry mouth—Epirubicin—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Ranolazine—Dermatitis—Triamcinolone—hematologic cancer	4.29e-05	0.000121	CcSEcCtD
Ranolazine—Vertigo—Doxorubicin—hematologic cancer	4.28e-05	0.000121	CcSEcCtD
Ranolazine—Anorexia—Methotrexate—hematologic cancer	4.28e-05	0.000121	CcSEcCtD
Ranolazine—Syncope—Doxorubicin—hematologic cancer	4.27e-05	0.000121	CcSEcCtD
Ranolazine—Urticaria—Prednisone—hematologic cancer	4.27e-05	0.000121	CcSEcCtD
Ranolazine—Leukopenia—Doxorubicin—hematologic cancer	4.27e-05	0.000121	CcSEcCtD
Ranolazine—Headache—Triamcinolone—hematologic cancer	4.26e-05	0.00012	CcSEcCtD
Ranolazine—Abdominal pain—Prednisone—hematologic cancer	4.25e-05	0.00012	CcSEcCtD
Ranolazine—Confusional state—Epirubicin—hematologic cancer	4.24e-05	0.00012	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—UGT1A1—hematologic cancer	4.23e-05	0.00094	CbGpPWpGaD
Ranolazine—Palpitations—Doxorubicin—hematologic cancer	4.21e-05	0.000119	CcSEcCtD
Ranolazine—Hypotension—Methotrexate—hematologic cancer	4.2e-05	0.000119	CcSEcCtD
Ranolazine—Loss of consciousness—Doxorubicin—hematologic cancer	4.19e-05	0.000118	CcSEcCtD
Ranolazine—Cough—Doxorubicin—hematologic cancer	4.16e-05	0.000118	CcSEcCtD
Ranolazine—Shock—Epirubicin—hematologic cancer	4.14e-05	0.000117	CcSEcCtD
Ranolazine—Nervous system disorder—Epirubicin—hematologic cancer	4.12e-05	0.000116	CcSEcCtD
Ranolazine—Thrombocytopenia—Epirubicin—hematologic cancer	4.12e-05	0.000116	CcSEcCtD
Ranolazine—Skin disorder—Epirubicin—hematologic cancer	4.08e-05	0.000115	CcSEcCtD
Ranolazine—Dizziness—Dexamethasone—hematologic cancer	4.08e-05	0.000115	CcSEcCtD
Ranolazine—Dizziness—Betamethasone—hematologic cancer	4.08e-05	0.000115	CcSEcCtD
Ranolazine—Hyperhidrosis—Epirubicin—hematologic cancer	4.06e-05	0.000115	CcSEcCtD
Ranolazine—Insomnia—Methotrexate—hematologic cancer	4.06e-05	0.000115	CcSEcCtD
Ranolazine—Anxiety—Doxorubicin—hematologic cancer	4.04e-05	0.000114	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—KRAS—hematologic cancer	4.04e-05	0.000898	CbGpPWpGaD
Ranolazine—Nausea—Triamcinolone—hematologic cancer	4.04e-05	0.000114	CcSEcCtD
Ranolazine—Paraesthesia—Methotrexate—hematologic cancer	4.03e-05	0.000114	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	4.03e-05	0.000114	CcSEcCtD
Ranolazine—Anorexia—Epirubicin—hematologic cancer	4.01e-05	0.000113	CcSEcCtD
Ranolazine—Dyspnoea—Methotrexate—hematologic cancer	4e-05	0.000113	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—JAK2—hematologic cancer	4e-05	0.000888	CbGpPWpGaD
Ranolazine—Somnolence—Methotrexate—hematologic cancer	3.99e-05	0.000113	CcSEcCtD
Ranolazine—Dry mouth—Doxorubicin—hematologic cancer	3.97e-05	0.000112	CcSEcCtD
Ranolazine—Dyspepsia—Methotrexate—hematologic cancer	3.95e-05	0.000112	CcSEcCtD
Ranolazine—Hypotension—Epirubicin—hematologic cancer	3.93e-05	0.000111	CcSEcCtD
Ranolazine—Vomiting—Betamethasone—hematologic cancer	3.92e-05	0.000111	CcSEcCtD
Ranolazine—Vomiting—Dexamethasone—hematologic cancer	3.92e-05	0.000111	CcSEcCtD
Ranolazine—Confusional state—Doxorubicin—hematologic cancer	3.92e-05	0.000111	CcSEcCtD
Ranolazine—Decreased appetite—Methotrexate—hematologic cancer	3.91e-05	0.00011	CcSEcCtD
Ranolazine—Rash—Betamethasone—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Ranolazine—Rash—Dexamethasone—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Ranolazine—Dermatitis—Betamethasone—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Ranolazine—Dermatitis—Dexamethasone—hematologic cancer	3.89e-05	0.00011	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.88e-05	0.00011	CcSEcCtD
Ranolazine—Fatigue—Methotrexate—hematologic cancer	3.87e-05	0.000109	CcSEcCtD
Ranolazine—Headache—Betamethasone—hematologic cancer	3.87e-05	0.000109	CcSEcCtD
Ranolazine—Headache—Dexamethasone—hematologic cancer	3.87e-05	0.000109	CcSEcCtD
Ranolazine—Asthenia—Prednisone—hematologic cancer	3.86e-05	0.000109	CcSEcCtD
Ranolazine—Shock—Doxorubicin—hematologic cancer	3.83e-05	0.000108	CcSEcCtD
Ranolazine—Nervous system disorder—Doxorubicin—hematologic cancer	3.81e-05	0.000108	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—MAPK14—hematologic cancer	3.81e-05	0.000847	CbGpPWpGaD
Ranolazine—Thrombocytopenia—Doxorubicin—hematologic cancer	3.81e-05	0.000108	CcSEcCtD
Ranolazine—Pruritus—Prednisone—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Ranolazine—Insomnia—Epirubicin—hematologic cancer	3.8e-05	0.000107	CcSEcCtD
Ranolazine—CYP3A4—Tryptophan metabolism—MDM2—hematologic cancer	3.79e-05	0.000841	CbGpPWpGaD
Ranolazine—Skin disorder—Doxorubicin—hematologic cancer	3.78e-05	0.000107	CcSEcCtD
Ranolazine—Paraesthesia—Epirubicin—hematologic cancer	3.77e-05	0.000107	CcSEcCtD
Ranolazine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.76e-05	0.000106	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—MET—hematologic cancer	3.75e-05	0.000834	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDK4—hematologic cancer	3.75e-05	0.000834	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—GSTP1—hematologic cancer	3.75e-05	0.000833	CbGpPWpGaD
Ranolazine—Dyspnoea—Epirubicin—hematologic cancer	3.75e-05	0.000106	CcSEcCtD
Ranolazine—Somnolence—Epirubicin—hematologic cancer	3.74e-05	0.000106	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—MTR—hematologic cancer	3.72e-05	0.000826	CbGpPWpGaD
Ranolazine—Anorexia—Doxorubicin—hematologic cancer	3.71e-05	0.000105	CcSEcCtD
Ranolazine—Feeling abnormal—Methotrexate—hematologic cancer	3.7e-05	0.000105	CcSEcCtD
Ranolazine—Dyspepsia—Epirubicin—hematologic cancer	3.7e-05	0.000105	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTP1—hematologic cancer	3.7e-05	0.000822	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.68e-05	0.000816	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Methotrexate—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Ranolazine—Nausea—Betamethasone—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Ranolazine—Nausea—Dexamethasone—hematologic cancer	3.67e-05	0.000104	CcSEcCtD
Ranolazine—Decreased appetite—Epirubicin—hematologic cancer	3.65e-05	0.000103	CcSEcCtD
Ranolazine—Hypotension—Doxorubicin—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Ranolazine—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.63e-05	0.000103	CcSEcCtD
Ranolazine—Fatigue—Epirubicin—hematologic cancer	3.62e-05	0.000102	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—NOTCH1—hematologic cancer	3.61e-05	0.000803	CbGpPWpGaD
Ranolazine—Constipation—Epirubicin—hematologic cancer	3.59e-05	0.000102	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—EP300—hematologic cancer	3.58e-05	0.000796	CbGpPWpGaD
Ranolazine—Urticaria—Methotrexate—hematologic cancer	3.57e-05	0.000101	CcSEcCtD
Ranolazine—Dizziness—Prednisone—hematologic cancer	3.55e-05	0.0001	CcSEcCtD
Ranolazine—Abdominal pain—Methotrexate—hematologic cancer	3.55e-05	0.0001	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—GSTT1—hematologic cancer	3.54e-05	0.000786	CbGpPWpGaD
Ranolazine—Insomnia—Doxorubicin—hematologic cancer	3.52e-05	9.94e-05	CcSEcCtD
Ranolazine—Paraesthesia—Doxorubicin—hematologic cancer	3.49e-05	9.87e-05	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—SRC—hematologic cancer	3.48e-05	0.000774	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PTPN11—hematologic cancer	3.47e-05	0.000771	CbGpPWpGaD
Ranolazine—Dyspnoea—Doxorubicin—hematologic cancer	3.47e-05	9.8e-05	CcSEcCtD
Ranolazine—Feeling abnormal—Epirubicin—hematologic cancer	3.46e-05	9.79e-05	CcSEcCtD
Ranolazine—Somnolence—Doxorubicin—hematologic cancer	3.46e-05	9.77e-05	CcSEcCtD
Ranolazine—CYP2D6—Biological oxidations—GSTM1—hematologic cancer	3.45e-05	0.000766	CbGpPWpGaD
Ranolazine—Gastrointestinal pain—Epirubicin—hematologic cancer	3.44e-05	9.71e-05	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—HRAS—hematologic cancer	3.44e-05	0.000763	CbGpPWpGaD
Ranolazine—Dyspepsia—Doxorubicin—hematologic cancer	3.42e-05	9.67e-05	CcSEcCtD
Ranolazine—Vomiting—Prednisone—hematologic cancer	3.42e-05	9.66e-05	CcSEcCtD
Ranolazine—CYP2D6—Metapathway biotransformation—GSTM1—hematologic cancer	3.4e-05	0.000755	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—hematologic cancer	3.39e-05	0.000754	CbGpPWpGaD
Ranolazine—Rash—Prednisone—hematologic cancer	3.39e-05	9.58e-05	CcSEcCtD
Ranolazine—Dermatitis—Prednisone—hematologic cancer	3.39e-05	9.57e-05	CcSEcCtD
Ranolazine—Decreased appetite—Doxorubicin—hematologic cancer	3.38e-05	9.55e-05	CcSEcCtD
Ranolazine—Headache—Prednisone—hematologic cancer	3.37e-05	9.51e-05	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—CREB1—hematologic cancer	3.36e-05	0.000747	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—STAT3—hematologic cancer	3.36e-05	0.000746	CbGpPWpGaD
Ranolazine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.36e-05	9.49e-05	CcSEcCtD
Ranolazine—Fatigue—Doxorubicin—hematologic cancer	3.35e-05	9.48e-05	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—NRAS—hematologic cancer	3.35e-05	0.000744	CbGpPWpGaD
Ranolazine—Urticaria—Epirubicin—hematologic cancer	3.34e-05	9.44e-05	CcSEcCtD
Ranolazine—Constipation—Doxorubicin—hematologic cancer	3.33e-05	9.4e-05	CcSEcCtD
Ranolazine—Abdominal pain—Epirubicin—hematologic cancer	3.32e-05	9.39e-05	CcSEcCtD
Ranolazine—SCN9A—Axon guidance—IL6—hematologic cancer	3.29e-05	0.00073	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6R—hematologic cancer	3.28e-05	0.000729	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CREBBP—hematologic cancer	3.28e-05	0.000728	CbGpPWpGaD
Ranolazine—Asthenia—Methotrexate—hematologic cancer	3.22e-05	9.11e-05	CcSEcCtD
Ranolazine—SCN9A—Developmental Biology—MAPK3—hematologic cancer	3.21e-05	0.000713	CbGpPWpGaD
Ranolazine—Feeling abnormal—Doxorubicin—hematologic cancer	3.21e-05	9.06e-05	CcSEcCtD
Ranolazine—Nausea—Prednisone—hematologic cancer	3.19e-05	9.02e-05	CcSEcCtD
Ranolazine—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.18e-05	8.99e-05	CcSEcCtD
Ranolazine—Pruritus—Methotrexate—hematologic cancer	3.18e-05	8.98e-05	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—MAP2K1—hematologic cancer	3.13e-05	0.000695	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TGFB1—hematologic cancer	3.11e-05	0.000692	CbGpPWpGaD
Ranolazine—Urticaria—Doxorubicin—hematologic cancer	3.09e-05	8.73e-05	CcSEcCtD
Ranolazine—Abdominal pain—Doxorubicin—hematologic cancer	3.07e-05	8.69e-05	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—SRC—hematologic cancer	3.04e-05	0.000675	CbGpPWpGaD
Ranolazine—Asthenia—Epirubicin—hematologic cancer	3.02e-05	8.52e-05	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—FGF2—hematologic cancer	2.97e-05	0.000661	CbGpPWpGaD
Ranolazine—Pruritus—Epirubicin—hematologic cancer	2.97e-05	8.4e-05	CcSEcCtD
Ranolazine—Dizziness—Methotrexate—hematologic cancer	2.97e-05	8.39e-05	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—VEGFA—hematologic cancer	2.96e-05	0.000658	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—NRAS—hematologic cancer	2.93e-05	0.00065	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—TNF—hematologic cancer	2.91e-05	0.000646	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—KRAS—hematologic cancer	2.88e-05	0.000641	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PHYH—hematologic cancer	2.87e-05	0.000638	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FTCD—hematologic cancer	2.87e-05	0.000638	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GMPS—hematologic cancer	2.87e-05	0.000638	CbGpPWpGaD
Ranolazine—Vomiting—Methotrexate—hematologic cancer	2.86e-05	8.07e-05	CcSEcCtD
Ranolazine—SCN5A—Developmental Biology—JAK2—hematologic cancer	2.85e-05	0.000633	CbGpPWpGaD
Ranolazine—Rash—Methotrexate—hematologic cancer	2.83e-05	8e-05	CcSEcCtD
Ranolazine—Dermatitis—Methotrexate—hematologic cancer	2.83e-05	8e-05	CcSEcCtD
Ranolazine—Headache—Methotrexate—hematologic cancer	2.81e-05	7.95e-05	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—MAPK3—hematologic cancer	2.8e-05	0.000622	CbGpPWpGaD
Ranolazine—Asthenia—Doxorubicin—hematologic cancer	2.79e-05	7.89e-05	CcSEcCtD
Ranolazine—Dizziness—Epirubicin—hematologic cancer	2.78e-05	7.85e-05	CcSEcCtD
Ranolazine—Pruritus—Doxorubicin—hematologic cancer	2.75e-05	7.78e-05	CcSEcCtD
Ranolazine—Vomiting—Epirubicin—hematologic cancer	2.67e-05	7.55e-05	CcSEcCtD
Ranolazine—Nausea—Methotrexate—hematologic cancer	2.67e-05	7.54e-05	CcSEcCtD
Ranolazine—Rash—Epirubicin—hematologic cancer	2.65e-05	7.49e-05	CcSEcCtD
Ranolazine—Dermatitis—Epirubicin—hematologic cancer	2.65e-05	7.48e-05	CcSEcCtD
Ranolazine—Headache—Epirubicin—hematologic cancer	2.63e-05	7.44e-05	CcSEcCtD
Ranolazine—CYP2D6—Metabolism—SMPD3—hematologic cancer	2.63e-05	0.000584	CbGpPWpGaD
Ranolazine—Dizziness—Doxorubicin—hematologic cancer	2.57e-05	7.27e-05	CcSEcCtD
Ranolazine—SCN5A—Axon guidance—KRAS—hematologic cancer	2.52e-05	0.000559	CbGpPWpGaD
Ranolazine—Nausea—Epirubicin—hematologic cancer	2.5e-05	7.06e-05	CcSEcCtD
Ranolazine—Vomiting—Doxorubicin—hematologic cancer	2.47e-05	6.99e-05	CcSEcCtD
Ranolazine—Rash—Doxorubicin—hematologic cancer	2.45e-05	6.93e-05	CcSEcCtD
Ranolazine—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.45e-05	0.000545	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—HRAS—hematologic cancer	2.45e-05	0.000545	CbGpPWpGaD
Ranolazine—Dermatitis—Doxorubicin—hematologic cancer	2.45e-05	6.92e-05	CcSEcCtD
Ranolazine—Headache—Doxorubicin—hematologic cancer	2.44e-05	6.88e-05	CcSEcCtD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.42e-05	0.000537	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—hematologic cancer	2.35e-05	0.000521	CbGpPWpGaD
Ranolazine—Nausea—Doxorubicin—hematologic cancer	2.31e-05	6.53e-05	CcSEcCtD
Ranolazine—CYP2D6—Metabolism—B3GAT1—hematologic cancer	2.3e-05	0.00051	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ASNS—hematologic cancer	2.3e-05	0.00051	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—DCK—hematologic cancer	2.3e-05	0.00051	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.25e-05	0.000501	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—EP300—hematologic cancer	2.23e-05	0.000496	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.22e-05	0.000494	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HDC—hematologic cancer	2.18e-05	0.000484	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SRC—hematologic cancer	2.17e-05	0.000482	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT1—hematologic cancer	2.16e-05	0.000481	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—HRAS—hematologic cancer	2.14e-05	0.000475	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—hematologic cancer	2.11e-05	0.000469	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—STAT3—hematologic cancer	2.09e-05	0.000465	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NRAS—hematologic cancer	2.09e-05	0.000464	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—hematologic cancer	2.05e-05	0.000455	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—MAPK3—hematologic cancer	2e-05	0.000444	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CDA—hematologic cancer	1.99e-05	0.000443	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TGFB1—hematologic cancer	1.94e-05	0.000431	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PC—hematologic cancer	1.92e-05	0.000426	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.88e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.88e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.88e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GBA—hematologic cancer	1.85e-05	0.000411	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC35B2—hematologic cancer	1.85e-05	0.000411	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—TNF—hematologic cancer	1.81e-05	0.000402	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—KRAS—hematologic cancer	1.8e-05	0.000399	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.72e-05	0.000382	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTAP—hematologic cancer	1.69e-05	0.000376	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—HRAS—hematologic cancer	1.53e-05	0.000339	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—FHL2—hematologic cancer	1.51e-05	0.000335	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—DCK—hematologic cancer	1.5e-05	0.000334	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.5e-05	0.000334	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.5e-05	0.000334	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AGRN—hematologic cancer	1.48e-05	0.000329	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—hematologic cancer	1.46e-05	0.000325	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HDC—hematologic cancer	1.42e-05	0.000316	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—IDH2—hematologic cancer	1.4e-05	0.000312	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMMR—hematologic cancer	1.4e-05	0.000312	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT1—hematologic cancer	1.35e-05	0.0003	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ARNTL—hematologic cancer	1.32e-05	0.000293	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CDA—hematologic cancer	1.3e-05	0.000289	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CA9—hematologic cancer	1.28e-05	0.000285	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ACP5—hematologic cancer	1.28e-05	0.000285	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOR2—hematologic cancer	1.27e-05	0.000281	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PC—hematologic cancer	1.25e-05	0.000279	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.21e-05	0.000269	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GBA—hematologic cancer	1.21e-05	0.000269	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—IDH1—hematologic cancer	1.21e-05	0.000268	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTO1—hematologic cancer	1.19e-05	0.000265	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCC3—hematologic cancer	1.19e-05	0.000265	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TXN—hematologic cancer	1.19e-05	0.000265	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SPHK1—hematologic cancer	1.17e-05	0.000259	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—UGT1A1—hematologic cancer	1.12e-05	0.000249	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTAP—hematologic cancer	1.11e-05	0.000246	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CRABP1—hematologic cancer	1.09e-05	0.000242	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC22A1—hematologic cancer	1.09e-05	0.000242	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALOX5—hematologic cancer	1.06e-05	0.000236	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NUP98—hematologic cancer	1.03e-05	0.000229	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOA3—hematologic cancer	1e-05	0.000222	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ADCY7—hematologic cancer	1e-05	0.000222	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NUP214—hematologic cancer	9.93e-06	0.000221	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—FHL2—hematologic cancer	9.87e-06	0.000219	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCG2—hematologic cancer	9.73e-06	0.000216	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTR—hematologic cancer	9.73e-06	0.000216	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AGRN—hematologic cancer	9.68e-06	0.000215	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ENO2—hematologic cancer	9.54e-06	0.000212	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTT1—hematologic cancer	9.25e-06	0.000206	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMMR—hematologic cancer	9.18e-06	0.000204	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—IDH2—hematologic cancer	9.18e-06	0.000204	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SDC1—hematologic cancer	9.05e-06	0.000201	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ARNTL—hematologic cancer	8.63e-06	0.000192	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CA9—hematologic cancer	8.39e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ACP5—hematologic cancer	8.39e-06	0.000186	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOR2—hematologic cancer	8.28e-06	0.000184	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—IDH1—hematologic cancer	7.89e-06	0.000175	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCC3—hematologic cancer	7.8e-06	0.000173	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TXN—hematologic cancer	7.8e-06	0.000173	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTO1—hematologic cancer	7.8e-06	0.000173	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CD44—hematologic cancer	7.69e-06	0.000171	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NQO1—hematologic cancer	7.69e-06	0.000171	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SPHK1—hematologic cancer	7.64e-06	0.00017	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	7.34e-06	0.000163	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYCS—hematologic cancer	7.28e-06	0.000162	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	7.23e-06	0.000161	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.14e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.14e-06	0.000159	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALOX5—hematologic cancer	6.96e-06	0.000154	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NUP98—hematologic cancer	6.74e-06	0.00015	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ADCY7—hematologic cancer	6.54e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOA3—hematologic cancer	6.54e-06	0.000145	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NUP214—hematologic cancer	6.49e-06	0.000144	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTP1—hematologic cancer	6.41e-06	0.000142	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCG2—hematologic cancer	6.36e-06	0.000141	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTR—hematologic cancer	6.36e-06	0.000141	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ENO2—hematologic cancer	6.24e-06	0.000139	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ABCB1—hematologic cancer	6.07e-06	0.000135	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.05e-06	0.000134	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SDC1—hematologic cancer	5.91e-06	0.000131	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GSTM1—hematologic cancer	5.89e-06	0.000131	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOR1—hematologic cancer	5.89e-06	0.000131	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—hematologic cancer	5.21e-06	0.000116	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CD44—hematologic cancer	5.03e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NQO1—hematologic cancer	5.03e-06	0.000112	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYCS—hematologic cancer	4.76e-06	0.000106	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	4.73e-06	0.000105	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	4.38e-06	9.72e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.19e-06	9.32e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CREBBP—hematologic cancer	4.06e-06	9.01e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ABCB1—hematologic cancer	3.97e-06	8.82e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GSTM1—hematologic cancer	3.85e-06	8.56e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOR1—hematologic cancer	3.85e-06	8.56e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	3.85e-06	8.55e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ALB—hematologic cancer	3.8e-06	8.44e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	3.63e-06	8.07e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.41e-06	7.57e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	3.35e-06	7.45e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PTEN—hematologic cancer	2.9e-06	6.44e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.86e-06	6.36e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—EP300—hematologic cancer	2.76e-06	6.14e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.65e-06	5.89e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.52e-06	5.59e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ALB—hematologic cancer	2.48e-06	5.52e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.38e-06	5.28e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.19e-06	4.87e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	2.04e-06	4.54e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.89e-06	4.21e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—EP300—hematologic cancer	1.81e-06	4.01e-05	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKT1—hematologic cancer	1.67e-06	3.71e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.34e-06	2.97e-05	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKT1—hematologic cancer	1.09e-06	2.43e-05	CbGpPWpGaD
